Teenagers sensitized to more cat or dog allergen molecules may face higher chances of having asthma symptoms when exposed to pets.

More than 140 U.S. medical organizations are advocating for the passage of a bill that would increase NIH funding for fiscal ...

Colder weather is on the way, and cold air can be an asthma trigger. The Asthma and Allergy Foundation of America ...

The family of Olivia Grace Edwards, who tragically died in an Aberdeen car park the day before her ninth birthday, are now fundraising in support of the Asthma and Allergy Foundation ...

THE family of a tragic Scots schoolgirl who fell ill and died in a car park the day before her ninth birthday have revealed ...

Indoor air quality (IAQ) in schools is a critical but unevenly addressed public health issue. Poor IAQ negatively impacts asthma, absenteeism and learning outcomes. Yet state laws addressing school ...

After completion of an asthma outreach program in three communities in the Navajo Nation, the odds for routine asthma care ...

The National Asthma Council Australia (NAC) has announced the appointment of Pharmaceutical Society of Australia (PSA) nominee Dr Amanda Cross to the ...

Cold weather and air pollution can worsen bronchial asthma. Here’s why winter triggers flare-ups and how patients can reduce their risk.

A new option for hard-to-control asthma: The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma. Designed to reduce flare-ups: The injectable ...

Depemokimab-ulaa (Exdensur) is approved for severe asthma with an eosinophilic phenotype, offering protection with just two doses annually. Phase 3 trials demonstrated significant reductions in asthma ...

GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won European regulatory approval for two inflammatory disease indications. The European Medicines Agency's ...